Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial

BACKGROUND: Cardiovascular disease (CVD) is the most common complication and the leading cause of death in patients with chronic kidney disease (CKD). Accelerated atherosclerosis is a pathophysiological process that is vital to the occurrence of cardiovascular complications associated with CKD. Abno...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jiachuan, He, Ting, Yu, Zhikai, Yang, Ke, Chen, Feng, Cheng, Jingbo, Shi, Yu, Huang, Yinghui, Qiao, Yu, Li, Haiyang, Shen, Yunzhu, Zhao, Jinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792066/
https://www.ncbi.nlm.nih.gov/pubmed/33413594
http://dx.doi.org/10.1186/s13063-020-04992-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792066/
https://www.ncbi.nlm.nih.gov/pubmed/33413594
http://dx.doi.org/10.1186/s13063-020-04992-x

Ejemplares similares